Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

SMS Pharmaceuticals Ltd.

NSE: SMSPHARMA | BSE:532815

₹260.03 15.48 (6.33%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

243.30

Today’s High

263.70

52W low

91.00

52W High

263.70

Open Price

245.60

Prev. Close

196.9500

Volume

1011684.00

Value

263068190.52

Fundamentals

Market Cap

2201.20

Price to Earnings

44.20

Price to Book Value

4.10

Dividend Yield

0.10

PE to Growth

0.00

Op Revenue TTM

709.26

Net Profit TTM

49.83

Cash From Operating Activity

50.12

Return on Equity %

9.29

EMA & SMA

Bullish Moving Averages

16

Bearish Moving Averages

0

5Day EMA

247.5

10Day EMA

239.6

12Day EMA

237.1

20Day EMA

229.4

26Day EMA

225.3

50Day EMA

213.8

100Day EMA

195

200Day EMA

168.8

5Day SMA

248.4

10Day SMA

237.4

20Day SMA

225.6

30Day SMA

216.8

50Day SMA

212

100Day SMA

194.1

150Day SMA

170.8

200Day SMA

158.3

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

05 Jul, 2024

38.5

Week

39.2

Month

40.6

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

255.69

PIVOT

First Resistance

268.07

Second Resistance

276.12

Third Resistance

288.50

First Support

247.64

Second Support

235.26

Third Support

227.21

Relative Strength Index

74.11

Money Flow Index

85.44

MACD

11.82

MACD Signal

8.86

Average True Range

12.1

Average Directional Index

29.79

Rate of Change (21)

37.11

Rate of Change (125)

95.81

Commodity Channel Index

138.8

Williams %R

-6.5

BETA

1 Month

0.49

3 Month

0.69

1 Year

0.68

3 Year

0.25

PRICE CHANGE ANALYSIS

↑ 17.17%

1 Week

Low

High

221.52

263.73

↑ 42.09%

1 Month

Low

High

178

263.73

↑ 31.73%

3 Months

Low

High

175.25

263.73

↑ 94.85%

6 Months

Low

High

121.05

263.73

↑ 184.81%

1 Year

Low

High

91.05

263.73

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 247.44 162.97 167.45 135.85 150.68 151.02 160.05 65.19 61.35 123.38 176.06
Operating Expenses Qtr 212.31 132.60 138.82 108.68 126.18 130.54 145.82 64.81 65.21 93.97 127.65
Operating Profit Qtr 33.49 28.88 27.82 26.66 23.25 18.27 13.62 -0.43 -4.29 27.28 47.05
EBIDT Qtr Cr 35.13 30.37 28.63 27.17 24.50 20.48 14.23 0.38 -3.86 29.41 48.41
Depreciation Qtr 7.92 8.01 7.90 7.69 7.97 8.12 8.09 7.93 7.97 8.10 8.09
Net Profit Qtr 15.92 12.17 12.05 9.28 8.07 5.03 0.79 -9.81 9.06 10.51 25.27
Basic EPS Qtr 1.88 1.44 1.42 1.10 0.95 0.59 0.09 -1.16 1.07 1.24 2.99
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 713.72 526.94 525.07 566.63 417.06
Operating Expenses Annual Cr 592.42 467.35 405.39 442.07 332.03
Operating Profit Annual 116.84 54.70 114.48 121.11 79.92
Operating Profit Margin Annual % 16.37 10.38 21.80 21.37 19.16
Total Expenses Annual Cr 647.39 521.39 456.42 475.51 366.30
EBIDT Annual Cr 121.30 59.59 119.68 124.56 85.03
EBIDT Annual margin % 17.00 11.31 22.79 21.98 20.39
Depreciation 31.52 32.13 32.15 22.28 22.07
PAT Before ExtraOrdinary Items Annual Cr 49.42 4.08 68.04 60.96 32.69
Net Profit Annual 49.42 4.08 68.04 60.96 32.69
Basic EPS Annual 5.84 0.48 8.04 7.20 3.86
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 570.49 495.10 493.76 428.22 367.42
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 166.05 164.17 192.73 207.59 114.47
Total Current Liabilities Annual Cr 331.72 254.91 196.48 194.09 145.21
Total Capital Plus Liabilities Annual Cr 1068.25 914.18 882.97 829.91 627.10
Fixed Assets Annual 467.53 445.21 449.00 464.11 322.61
Total Non Current Assets Annual 534.36 503.54 505.92 520.58 408.32
Total Current Assets Annual 533.89 410.65 377.05 309.33 218.78
Total Assets Annual 1068.25 914.18 882.97 829.91 627.10
Contingent Liabilities plus Commitments Annual Cr - 132.30 138.21 65.97 159.50
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 50.12 22.45 40.23 90.45 39.71
Cash from Investing Activity Annual -52.07 -29.69 -27.15 -151.59 -42.56
Cash from Financing Annual Activity 30.68 -31.97 -6.92 92.02 -2.40
Net Cash Flow Annual - -39.20 6.16 30.88 -5.25
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 67.39 58.49 58.33 50.59 43.40
ROE Annual % 8.66 0.82 13.77 14.23 8.89
ROCE Annual % 12.19 4.16 12.75 16.08 13.06
Total Debt to Total Equity Annual 0.49 0.51 0.53 0.51 0.35
EBDIT Annual Margin % 17.10 11.41 23.02 22.11 20.64
Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 247.44 162.97 167.45 135.85 150.68 151.02 160.05 65.19 61.35 123.38 176.06
Operating Expenses Qtr 212.18 132.48 138.82 109.16 126.19 130.29 145.87 65.20 65.36 94.21 127.91
Operating Profit Qtr 33.62 29.00 27.82 26.18 23.24 18.51 13.56 -0.81 -4.44 27.05 46.80
EBIDT Qtr Cr 35.26 30.49 28.63 26.70 24.49 20.73 14.17 -0.01 -4.02 29.17 48.15
Depreciation Qtr 7.92 8.01 7.90 7.69 7.97 8.12 8.09 7.93 7.97 8.10 8.09
Net Profit Qtr 17.28 11.48 11.73 9.34 6.22 3.76 -2.01 -12.77 6.17 10.27 23.03
Basic EPS Qtr 2.04 1.36 1.39 1.10 0.73 0.44 -0.24 -1.51 0.73 1.07 2.72
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 713.72 526.94 525.07 566.63 417.06
Operating Expenses Annual Cr 592.64 467.55 405.55 442.07 332.03
Operating Profit Annual 116.62 54.50 114.33 121.11 79.92
Operating Profit Margin Annual % 16.34 10.34 21.77 21.37 19.16
Total Expenses Annual Cr 647.62 521.59 456.57 475.51 366.30
EBIDT Annual Cr 121.08 59.39 119.53 124.56 85.03
EBIDT Annual margin % 16.96 11.27 22.76 21.98 20.39
Depreciation 31.52 32.13 32.15 22.28 22.07
PAT Before ExtraOrdinary Items Annual Cr 49.20 3.88 67.88 60.96 32.69
Net Profit Annual 49.83 -7.06 62.22 62.53 31.57
Basic EPS Annual 5.89 -0.83 7.35 7.39 3.73
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 536.33 460.53 470.29 410.53 348.24
Minority Interest Liability Annual Cr 0.00 0.00 0.00 0.00 0.00
Total Non Current Liabilities Annual Cr 166.05 164.17 192.73 207.59 114.47
Total Current Liabilities Annual Cr 331.72 254.91 196.48 194.09 145.21
Total Capital Plus Liabilities Annual Cr 1034.09 879.61 859.50 812.21 607.91
Fixed Assets Annual 467.53 445.21 449.00 464.11 322.61
Total Non Current Assets Annual 500.20 468.96 482.45 502.88 389.13
Total Current Assets Annual 533.89 410.65 377.05 309.33 218.78
Total Assets Annual 1034.09 879.61 859.50 812.21 607.91
Contingent Liabilities plus Commitments Annual Cr - 132.30 138.21 65.97 159.50
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 50.12 22.45 40.23 90.45 39.71
Cash from Investing Activity Annual -52.07 -29.69 -27.15 -151.59 -42.56
Cash from Financing Annual Activity 30.68 -31.97 -6.92 92.02 -2.40
Net Cash Flow Annual - -39.20 6.16 30.88 -5.25
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 63.36 54.40 55.56 48.50 41.14
ROE Annual % 9.29 -1.53 13.23 15.23 9.06
ROCE Annual % 12.75 4.36 13.17 16.54 13.60
Total Debt to Total Equity Annual 0.52 0.55 0.55 0.53 0.37
EBDIT Annual Margin % 17.07 11.37 22.99 22.11 20.64
Name Holding Percent Holding Id Pledged % Locked %
Name Holding Percent Holding Id Pledged % Locked %
Ramesh Babu Potluri 18.49 74553185 0 100
HIMA BINDU POTLURI 17.73 74553186 70.76 0
Vamsi Krishna Potluri 15.74 74553187 0 100
TRILOK POTLURI 2.58 74553188 0 100
POTLURI INFRA PROJECTS LLP 8.68 74553190 0 100
POTLURI LABORATORIES PRIVATE LIMITED 1.32 74553191 0 0
Name Holding Percent Holding Id
QUANT MUTUAL FUND - QUANT HEALTHCARE FUND 1.98 74553195
Name Holding Percent Holding Id
VENKATA SUBBARAJU PENMATSA . 2.13 74553206
VENKATA PRAVEEN TALLURI 1.56 74553208
SUDEEPTHI GOPINEEDI 1.56 74553207
VIVEK MUNDRA 1.23 74553210
ANIRUDDH MUNDRA 1.13 74553211
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Sep 22, 2023 0.3 FINAL Sep 22, 2023 Equity Share
Sep 22, 2022 0.3 FINAL Sep 23, 2022 Equity Share
Sep 22, 2021 0.3 FINAL - Equity Share
Mar 26, 2020 0.25 INTERIM Mar 28, 2020 Equity Share
Sep 19, 2019 0.25 FINAL - Equity Share
Sep 11, 2018 0.25 FINAL - Equity Share
Sep 20, 2017 0.2 FINAL - Equity Share
Sep 22, 2016 0.2 FINAL - Equity Share
Sep 22, 2015 2 FINAL - Equity Share
Sep 23, 2014 2 FINAL - Equity Share
Sep 23, 2013 2 FINAL - Equity Share
Sep 22, 2011 1.5 FINAL - Equity Share
Sep 23, 2010 1 FINAL - Equity Share
Sep 23, 2009 2 FINAL - Equity Share
Dec 23, 2008 2 FINAL - Equity Share
Sep 21, 2007 2 FINAL - Equity Share
Ex-Date Split Ratio Record Date
Dec 17, 2015 10:1 -
Ex-Date Purpose Notes
May 29, 2024 Audited Results & Final Dividend -
Feb 08, 2024 Quarterly Results & Preferential issue -
Nov 08, 2023 Quarterly Results -
Aug 08, 2023 Quarterly Results -
May 24, 2023 Audited Results & Final Dividend -
Feb 09, 2023 Quarterly Results -
Nov 12, 2022 Quarterly Results -
Aug 13, 2022 Quarterly Results -
May 30, 2022 Audited Results & Final Dividend -
Feb 09, 2022 Quarterly Results -
Nov 12, 2021 Quarterly Results -
Aug 07, 2021 Quarterly Results -
May 28, 2021 Audited Results -
Feb 10, 2021 Quarterly Results -
Nov 03, 2020 Quarterly Results -
Aug 12, 2020 Quarterly Results -
Jun 05, 2020 Audited Results & Others Inter alia, to cnsider Appointment of Mr. Vamsi Krishna Potluri as Additional Director.
Mar 18, 2020 Interim Dividend -
Feb 12, 2020 Quarterly Results -
Nov 12, 2019 Quarterly Results -
Aug 12, 2019 Quarterly Results -
May 27, 2019 Quarterly Results & Dividend -
Feb 14, 2019 Quarterly Results -
Nov 10, 2018 Quarterly Results -
Jul 28, 2018 Quarterly Results -
May 26, 2018 Audited Results, Dividend & Others -
Feb 08, 2018 Quarterly Results -
Dec 13, 2017 Quarterly Results -
Sep 27, 2017 Others -
Sep 13, 2017 Quarterly Results -
Aug 11, 2017 Others -
May 30, 2017 Audited Results & Dividend -
Feb 11, 2017 Quarterly Results & Others To consider the proposal for further investment in VKT Pharma Pvt Ltd, an associate Company by way of subscription to the equity shares.
Nov 05, 2016 Quarterly Results -
Aug 13, 2016 Spin Off -
Aug 10, 2016 Quarterly Results & Others Draft Scheme of Demerger.
May 14, 2016 Audited Results & Final Dividend -
Mar 30, 2016 Others 1. To consider the Report of Independent Committee for checkout the feasibility of Demerger. 2. To consider the proposal of Corporate Guarantee to its associate companies.
Feb 11, 2016 Quarterly Results 1. The Board has considered and approved the Draft Document Preservation Policy. 2. The Board has also considered and approved the Draft Policy for Determination of Materiality of Disclosures.
Dec 05, 2015 Others Interalia, to Declare the Result of Postal Ballot and fix Record Date (if any) for stock split.
Nov 07, 2015 Quarterly Results & Others The Board has appointed Mr. P. S. Rao as Additional Independent Director.
Oct 09, 2015 Stock Split & Others To consider stock split i.e. Sub-division of equity Shares as per ratio finalize by the Board.
Aug 08, 2015 Quarterly Results & Others 1. To fix the time, date, book closure and venue to convene the 27th Annual General Meeting of the Company. 2. To re-appoint the Statutory Auditors.
May 30, 2015 Audited Results & Dividend -
Feb 06, 2015 Quarterly Results -
Nov 11, 2014 Quarterly Results -
Aug 26, 2014 Others 1. To fix the time, date, book closure and venue to convene the 26th AGM of the Company. 2. To re-appoint the Statutory Auditors.
Aug 12, 2014 Quarterly Results -
May 30, 2014 Audited Results & Dividend -
Feb 11, 2014 Quarterly Results -
Nov 11, 2013 Quarterly Results -
Aug 13, 2013 Quarterly Results & Others -
May 29, 2013 Audited Results & Dividend -
Feb 26, 2013 Buy Back of Shares -
Feb 12, 2013 Quarterly Results -
Nov 12, 2012 Quarterly Results -
Oct 16, 2012 Others To finalise and approve the prospective buyer and to finalise the consideration for Sale of the Unit-VI of the Company. (Revised)
Oct 13, 2012 Others -
Aug 18, 2012 Others 1. To consider the sale and transfer of Unit-VI situated at J.N. Pharma City, Parawada, Visakhapatnam, A.P. 2. To appoint Independent Valuers and legal advisors. 3. To appoint Scrutinizes.
Aug 10, 2012 Audited, Quarterly Results & Dividend -
May 10, 2012 Quarterly Results -
Feb 14, 2012 Quarterly Results -
Nov 02, 2011 Quarterly Results -
Aug 05, 2011 Audited, Quarterly Results & Dividend -
May 12, 2011 Quarterly Results -
Jan 29, 2011 Quarterly Results -
Oct 30, 2010 Quarterly Results -
Aug 27, 2010 Audited Results & Dividend To fix the time, date and venue to convene the 22nd Annual General Meeting of the Company & to approve the draft notice convening the 22nd Annual General Meeting of the Company.
Jul 23, 2010 Quarterly Results -
May 12, 2010 Quarterly Results -
Jan 30, 2010 Quarterly Results -
Oct 28, 2009 Quarterly Results -
Aug 10, 2009 Audited Results -
Jul 25, 2009 Quarterly Results & Others To consider the enhancement of the Borrowing powers from Rs 125.00 crores to Rs 300.00 crores, subject to the approval of the Shareholders of the Company in the forthcoming AGM of the Company.
Apr 30, 2009 Quarterly Results -
Jan 27, 2009 Quarterly Results -
Nov 29, 2008 Audited Results, Dividend & Others To allot 12,978 Equity Shares of Rs 10/- each to the erstwhile shareholders of M/s. Plant Organics Ltd & to implement the Board for Industrial & Financial Reconstruction.
Oct 31, 2008 Quarterly Results & Others To consider: Re-appointment of Mr. P Ramesh Babu, Chairman, Managing Director & Re-appointment of Mr. TVVSN Murthy, Vice-Chairman, Jt. Managing Director.
Jul 30, 2008 Quarterly Results & Others To consider Approval of Extra-Ordinary General Meeting of the Company to be held on August 26, 2008, in connection with the Merger of Plant Organics Ltd.
Apr 30, 2008 Quarterly Results -
Jan 31, 2008 Quarterly Results -
Oct 29, 2007 Quarterly Results -
Aug 27, 2007 Audited Results & Dividend -
Jul 30, 2007 Quarterly Results -
Apr 30, 2007 Quarterly Results -
Mar 28, 2007 To enter into MoU with Plant Organics To enter into Memorandum of Understanding with Plant Organics Ltd to entrust the job work for conversion of intermediates and other active pharma ingredients.
Ex-Date Bonus Ratio Record Date
Bigul
28 Jun 2024

SMS PHARMACEUTICALS LTD. - 532815 - Closure of Trading Window

 Intimation of closure of Trading Window.
Bigul
06 Jun 2024

SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Transcript of the Conference Call held on 31st May, 2024.
Bigul
31 May 2024

SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Audio recording of Analysts/Investors Conference Call pertaining to the Financial Results for the fourth quarter and financial year ended 31st March, 2024
Bigul
30 May 2024

SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Investor Presentation on Financial Results
Bigul
30 May 2024

SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Press Release on Financial Results
Bigul
30 May 2024

SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper Publication related to Financial Results
Bigul
29 May 2024

SMS PHARMACEUTICALS LTD. - 532815 - Disclosure Of Related Party Transactions For The Half Year Ended 31St March, 2024

 Please find enclosed herewith the disclosure of Related Party Transactions for the half year ended 31st March, 2024
Bigul
29 May 2024

SMS PHARMACEUTICALS LTD. - 532815 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Annual Secretarial Compliance Report for the Financial Year ended 31st March, 2024
Bigul
29 May 2024

SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Change in Management

 Intimation under Regulation 30 read with Schedule III of SEBI (LODR) Regulations, 2015.
Bigul
29 May 2024

SMS PHARMACEUTICALS LTD. - 532815 - Statement Of Deviation Or Variation In Utilisation Of Funds Raised Through Preferential Issue For The Quarter Ended 31St March, 2024.

 Statement of deviation/variation of fund raised through Preferential issue for the quarter ended 31st March, 2024.
See all News

FAQs

The latest market price of SMS Pharmaceuticals Ltd. on NSE was Rs. 260.03 as of today.

The opening share price of SMS Pharmaceuticals Ltd. was Rs. 245.60 as of today.

The 52-week high share price of SMS Pharmaceuticals Ltd. was Rs. 263.70.

The 52 week low share price of SMS Pharmaceuticals Ltd. was Rs. 91.00.

Please find Corporate actions section for more details.

The PE ratio of SMS Pharmaceuticals Ltd. is 0.00. Please refer to the Fundamentals section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by SMS Pharmaceuticals Ltd. was on 2023-09-22 for Rs. 0.3 per share. According to today’s share price, the dividend yield of SMS Pharmaceuticals Ltd. stands at 0.10. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

The latest split issue declared by SMS Pharmaceuticals Ltd. was as of 2015-12-17. The split ratio declared in this issue was 10:1. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about SMS Pharmaceuticals Ltd..

Close

Let's Open Free Demat Account